Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
AstraZeneca
Colorcon
Express Scripts

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Co. v. Zydus Pharmaceuticals USA (Fed. Cir. 2013)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Takeda Pharmaceutical Co. v. Zydus Pharmaceuticals USA
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceutical Co. v. Zydus Pharmaceuticals USA (Fed. Cir. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-05-15 1 NOA Package (the “ ‘994 patent”), 7,431,942 the “ ‘942 patent”), and 5,464,632 (the “ ‘632 patent”). Presently… “ ‘994 patent”), 7,431,942 (the “ ‘942 patent”), 7,875,292 (the “ ‘292 patent) and 5,464,632 (the “ … U.S. Patent No. 6,328,994 (the “‘994 patent”) and U.S. Patent No. 7,431,942 (the “‘942 patent”). The…#39;994 patent, '942 patent and the '632 patent shall …disputed claim terms in the ‘994 patent, ‘942 patent and the ‘632 patent shall be construed as set forth External link to document
2013-07-15 28 form, as JP-A-63-301816 and U.S. Pat. No. 5,026,560 disclose uniform as possible …States Patent No. 5,464,632 (the “'632 Patent”). All claims related to the '632 Patent were resolved…licensee of the patent-in-suit, U.S. Patent No. 6,328,994 ("the '994 Patent"). Id. …United States Patent Nos. 6,328,994 (the “'994 patent”), 7,431,942 (the “'942 patent”), 7,875,…7,875,292 (the “ ‘292 patent”) and 5,464,632 (the “ ‘632 patent”). The ‘632 patent expired on November External link to document
2013-08-29 32 with respect to all patents except U.S. Patent No. 6,328,994 (“the ’994 patent”), owned by Takeda. JA…doing so, the court rightly began with the patent itself. A patent’s specification is “the single best guide…CONVINCING EVIDENCE THAT THE PATENT IS INVALID. “A patent shall be presumed valid,” and the…Eli Lilly were patents that claimed particles of a certain size. Id. at 1344. The patents were construed… The District Court Properly Construed The Patent To Cover Fine Granules With An External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Colorcon
Merck
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.